Literature DB >> 16484503

Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences.

C Thomas1, J-F Landrier, D Gaillard, J Grober, M-C Monnot, A Athias, P Besnard.   

Abstract

BACKGROUND AND AIMS: Faecal bile acid elimination greatly contributes to cholesterol homeostasis. Synthesised from cholesterol in the liver, bile acids are actively reclaimed in the ileum by the apical sodium dependent bile acid transporter (ASBT). Although the expression level of ASBT affects body cholesterol balance, the impact of cholesterol on ASBT gene expression remains unclear. In this study, the effect of cholesterol on ASBT expression and ileal bile acid uptake was explored in vivo and in vitro.
METHODS: ASBT gene expression was assessed by real time quantitative polymerase chain reaction and northern or western blotting, or both, in mice subjected to a 2% cholesterol diet for two weeks, in mouse ileal explants, or in human enterocyte-like Caco-2 cells cultured in sterol enriched or depleted media. Bile acid uptake was determined by measuring [3H]-taurocholic acid influx into in situ isolated ileal loops from mice or into differentiated Caco-2 cells. Molecular analysis of mouse and human ASBT promoters was undertaken with reporter assays, site directed mutagenesis, and electrophoretic mobility shift assays.
RESULTS: In mice, cholesterol enriched diet triggered a downregulation of ASBT expression (mRNA and protein), a fall in ileal bile acid uptake, and a rise in the faecal excretion of bile acids. This effect was direct as it was reproduced ex vivo using mouse ileal explants and in vitro in differentiated Caco-2 cells.
CONCLUSIONS: This regulation, which involves an original partnership between SREBP-2 and HNF-1alpha transcription factors, affects ileal bile acid recycling and thus might participate in the maintenance of body cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16484503      PMCID: PMC1860007          DOI: 10.1136/gut.2005.085555

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  54 in total

Review 1.  Bile salt transporters: molecular characterization, function, and regulation.

Authors:  Michael Trauner; James L Boyer
Journal:  Physiol Rev       Date:  2003-04       Impact factor: 37.312

2.  Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter.

Authors:  Frank Chen; Lin Ma; Paul A Dawson; Christopher J Sinal; Ephraim Sehayek; Frank J Gonzalez; Jan Breslow; M Ananthanarayanan; Benjamin L Shneider
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

3.  Resistance of SHP-null mice to bile acid-induced liver damage.

Authors:  Li Wang; Yunqing Han; Chang-Soo Kim; Yoon-Kwang Lee; David D Moore
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

4.  Sterol regulatory element-binding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes.

Authors:  Koichi Misawa; Taro Horiba; Naoto Arimura; Yuko Hirano; Jun Inoue; Noriaki Emoto; Hitoshi Shimano; Makoto Shimizu; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2003-07-10       Impact factor: 5.157

5.  SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes.

Authors:  Takashi Yamamoto; Hitoshi Shimano; Yoshimi Nakagawa; Tomohiro Ide; Naoya Yahagi; Takashi Matsuzaka; Masanori Nakakuki; Akimitsu Takahashi; Hiroaki Suzuki; Hirohito Sone; Hideo Toyoshima; Ryuichiro Sato; Nobuhiro Yamada
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

Review 6.  The enzymes, regulation, and genetics of bile acid synthesis.

Authors:  David W Russell
Journal:  Annu Rev Biochem       Date:  2003-01-16       Impact factor: 23.643

7.  Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.

Authors:  B Ganesh Bhat; Stephen R Rapp; Judith A Beaudry; Nida Napawan; Dustie N Butteiger; Kerri A Hall; Christopher L Null; Yi Luo; Bradley T Keller
Journal:  J Lipid Res       Date:  2003-06-16       Impact factor: 5.922

8.  Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice.

Authors:  Paul A Dawson; Jamie Haywood; Ann L Craddock; Martha Wilson; Mary Tietjen; Kimberly Kluckman; Nobuyo Maeda; John S Parks
Journal:  J Biol Chem       Date:  2003-06-20       Impact factor: 5.157

Review 9.  Enterohepatic bile salt transporters in normal physiology and liver disease.

Authors:  Gerd A Kullak-Ublick; Bruno Stieger; Peter J Meier
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

10.  Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha.

Authors:  Bryan Goodwin; Michael A Watson; Hwajin Kim; Ji Miao; Jongsook Kim Kemper; Steven A Kliewer
Journal:  Mol Endocrinol       Date:  2002-12-12
View more
  13 in total

1.  LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.

Authors:  Masae Okuwaki; Tappei Takada; Yuki Iwayanagi; Saori Koh; Yoshiaki Kariya; Hiroshi Fujii; Hiroshi Suzuki
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

Review 2.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 3.  Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.

Authors:  Jessica Tsuei; Thinh Chau; David Mills; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2014-06-20

Review 4.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

5.  SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin.

Authors:  Pradeep Kumar; Pooja Malhotra; Ke Ma; Amika Singla; Omar Hedroug; Seema Saksena; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-04-28       Impact factor: 4.052

Review 6.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

7.  Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption.

Authors:  Masaaki Miyata; Yoshiki Matsuda; Masahiro Nomoto; Yuki Takamatsu; Nozomi Sato; Mayumi Hamatsu; Paul A Dawson; Frank J Gonzalez; Yasushi Yamazoe
Journal:  Drug Metab Dispos       Date:  2008-11-06       Impact factor: 3.922

8.  Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression.

Authors:  Olga Renner; Simone Harsch; Elke Schaeffeler; Matthias Schwab; Dietmar M Klass; Wolfgang Kratzer; Eduard F Stange
Journal:  Hum Genet       Date:  2009-01-30       Impact factor: 4.132

Review 9.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

10.  A single element in the 3'UTR of the apical sodium-dependent bile acid transporter controls both stabilization and destabilization of mRNA.

Authors:  Dellys M Soler; Ayantika Ghosh; Frank Chen; Benjamin L Shneider
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.